Advancing Precision Equity With Multicancer Detection Liquid Biopsies

JAMA Oncol. 2024 Aug 1;10(8):1023-1024. doi: 10.1001/jamaoncol.2024.1860.

Nicholas P Semenkovich^{1

2

3}, Gautum Agarwal^{4

5

6}, Aadel A Chaudhuri^{7

8}

¹ Data Science Institute, Medical College of Wisconsin, Milwaukee.
² Department of Medicine, Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin, Milwaukee.
³ Department of Medicine, Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin.
⁴ Office of Precision Medicine, Mercy Clinic, St Louis, Missouri.
⁵ Division of Urologic Oncology, Mercy Clinic, St Louis, Missouri.
⁶ David C. Pratt Cancer Center, Mercy Clinic, St Louis, Missouri.
⁷ Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
⁸ Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota.

No abstract available

Plain language summary

This Viewpoint discusses the clinical and socioeconomic potential of multicancer detection liquid biopsies.